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P U B L I S H E D B Y E L S E V I E R I N C .LETTERS TO THE EDITORIncremental Prognostic Value of Estimated
LV End-Diastolic Volume by Cardiac CTIdentifying characteristics that predict future adverse
events can be used to facilitate patient monitoring or
therapy. Although, computed tomographic coronary
angiography (CTCA) measures of coronary athero-
sclerosis, coronary artery disease severity, and left
ventricular (LV) ejection fraction are prognostic
markers of major adverse events, other potential
measures have not been fully explored (1). Previous
studies have demonstrated that left ventricular
end-diastolic volume (LVEDV) has incremental prog-
nostic value (2). However, the adoption of prospec-
tive electrocardiogram (ECG)-triggered CTCA hasTABLE 1 Baseline Characteristics of MACE Population and Control Po
MACE Population
(n ¼ 97)
Age, yrs 66.5  9.9 (64.5–68.
Men 59 (60.8)
Body mass index, kg/m2 28.5  6.1 (27.3–29.7
Cardiac risk factors
Smoker/ex-smoker 77 (79.4)
Hypertension 63 (64.9)
Dyslipidemia 67 (69.1)
Diabetes 27 (27.8)
Family history of CAD 42 (43.3)
Symptoms
Dyspnea 68 (70.1)
Chest pain 52 (53.6)
Cardiac history
Morise score 13.8  0.34 (13.1–14.5
Prior CAD 51 (52.6)
Congestive heart failure 20 (20.6)
Congenital heart disease 4 (4.1)
Equivocal stress test 27 (28.1)
High-risk CAD 32 (33.0)
Follow-up, days 450  283 (394–507
Imaging characteristics
Heart rate, beats/min 58.4  7.2 (57.0–59.
Systolic blood pressure, mm Hg 124.1  19.9 (120.1–128
Diastolic blood pressure, mm Hg 65.0  11.3 (62.7–67.3
LA volume indexed, ml/m2* 64.0  2.1 (59.9–68.
LV volume indexed, ml/m2* 73.5  3.9 (65.9–81.2
LVEDVIEstimated, ml/m
2 91.7  4.3 (83.1–100
LVEDVIMeasured, ml/m
2 89.2  3.6 (82.0–96.
Values are mean  SD (range) or n (%). *Indexed in diastasis.
CAD ¼ coronary artery disease; LA ¼ left atrium; LV ¼ left ventricle; LVEDVI ¼ left veliminated the ability to directly measure LVEDV. It
has previously been shown that LVEDV can be esti-
mated using LV and left atrial (LA) volumes obtained
during ventricular diastasis (3). The prognostic value
of estimated LVEDV (LVEDVEstimated) is unknown.
The objective of our study was to validate the pre-
dictive model for LVEDV and determine the incre-
mental prognostic value of LVEDVEstimated.
Using the University of Ottawa Heart Institute
Cardiac CT Registry, 97 patients who experienced
major adverse events (all-cause mortality and
nonfatal myocardial infarction [MI]) were identiﬁed
(1). A matched (Morise score) control population of
98 patients was randomly selected from the same
registry. The details of the CTCA procedure have been
described previously (1). In brief, a triphasic intrave-
nous contrast administration protocol was used for
ﬁnal image acquisition. Retrospective ECG-gated
datasets were acquired with the GE Volume CT (GE,pulation
Control Population
(n ¼ 98) p Value
4) 65.9  9.8 (64.0–67.9) 0.630
63 (64.9) 0.721
) 29.5  5.1 (28.5–30.5) 0.245
65 (67.0) 0.556
60 (61.9) 0.245
61 (62.9) 0.773
22 (22.7) 0.457
40 (41.2) 0.112
62 (63.9) 0.023
59 (60.2) 0.936
) 13.8  0.32 (13.1–14.4) 0.874
21 (21.6) <0.0001
9 (9.3) 0.758
1 (1.0) 0.02
16 (16.7) 0.02
14 (14.4) <0.0001
) 757  371 (683–831) 0.008
9) 56.4  7.9 (54.8–57.9) 0.057
.1) 129.1  17.3 (125.7–132.6) 0.060
) 68.6  9.3 (66.7–70.5) 0.02
1) 50.4  1.2 (48.1–52.8) <0.0001
) 55.4  2.3 (50.9–60.0) <0.001
.2) 69.7  2.5 (64.6–74.7) <0.0001
4) 70.2  2.3 (65.7–74.7) <0.0001
entricular end-diastolic volume index; MACE ¼ major adverse cardiac event(s).
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1281Milwaukee, Wisconsin) with 64  0.625 mm slice
collimation. The 5% to 95% phases (10% increments)
were reconstructed using a slice thickness of 1.25 mm
and an increment of 0.625 mm. CTCA images were
post-processed using the GE Advantage Volume
Share Workstation and interpreted by expert ob-
servers blinded to all clinical data. LV and LA
volumes were measured using the 75% phase and at
end-diastole. Using a previously developed model for
LVEDVEstimated, LVEDVEstimated was calculated from
LV and LA volumes at the 75% phase [LVEDV ¼
(1.021  LV75% phase volume) þ (0.259  LA75%
phase volume)] (3). LVEDVEstimated was indexed
(LVEDVIEstimated) to the body surface area for analysis.
Continuous variables were expressed as mean 
SD and categorical variables as proportions or per-
centages. Statistical signiﬁcance was deﬁned as
p < 0.05. The Student t test was used to compare
continuous variables and the chi-square test was
used for categorical variables. The prognostic value of
LVEDVIEstimated was assessed using Cox proportional
hazard models for the composite of all-cause death
and nonfatal MI. A total of 195 consecutive patients
were analyzed. The baseline characteristics and the
imaging characteristics of the test and control pop-
ulations were similar (Table 1). Mean follow-up dura-
tion was higher (p ¼ 0.008) for the test population
than for the control population (450  283 days vs.
757  371 days).
The LV and LA volume indices, at diastasis, were
greater in the event cohort than in the control group
(Table 1). Using these measures, LVEDVIEstimated was
calculated and compared with “true” CTCA-measured
LVEDV. The correlation between measured LVEDVI
and LVEDVIEstimated was very good (r ¼ 0.910,
95% conﬁdence interval [95% CI]: 0.882 to 0.931;
p < 0.0001). LVEDVIEstimated was signiﬁcantly larger in
the event population than in the control population
(91.7  4.3 ml/m2 and 69.7  2.5 ml/m2, respectively;
p # 0.0001).
In a Cox proportional hazards regression ana-
lyses, previous coronary artery disease (hazard ratio
[HR]: 1.89, 95% CI: 1.248 to 2.865; p ¼ 0.003) and
LVEDVIEstimated (HR: 1.008, 95% CI: 1.004 to 1.012;
p ¼ 0.001) emerged as univariate predictors of
all-cause death and nonfatal MI. However, when
multivariate survival analysis was performed using
signiﬁcant univariate predictors as variables, only
LVEDVIEstimated (HR: 1.01, 95% CI: 1.003 to 1.012;
p ¼ 0.02) emerged as a predictor of all-cause death
and nonfatal MI.
Previous studies have shown that LVEDV assessed
by different cardiac imaging modalities has indepen-
dent and incremental prognostic value in identifyingpatients at high risk of cardiac events (2,4). However,
to the best of our knowledge, the incremental
prognostic ability of LVEDV assessed by CTCA has
not been demonstrated before. Moreover, to mini-
mize patient radiation exposure, prospective ECG-
triggered CTCA has been adopted into routine
clinical practice. Because prospective ECG-triggered
CTCA does not permit the direct assessment of LV
ejection fraction and LVEDV, the ability to estimate
LVEDV would be clinically desirable.
Our group has previously developed a model for
estimating LVEDV from prospective ECG-gated CTCA
datasets. In the current study, we were able to vali-
date this model and additionally demonstrate the
prognostic value of LVEDV measurements from this
predictive formula.Kevin E. Boczar, BSc
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Chest 1986;89:352–6.Cardiopulmonary Changes in Healthy Children
Residing at High Altitude in ChinaAbout 140 million people worldwide, 80 million of
them in Asia, live at an altitude above 2,500 m. High-
altitude dwellers exhibit important physiological and
